Dipyridamole Injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Dipyridamole Injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dipyridamole
Brand name: Persantine, Persantine IV
Synonyms: Dipyridamole
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dipyridamole Injection-Insulin degludec
- Dipyridamole Injection-Insulin Degludec (U-100) Prefilled Pens
- Dipyridamole Injection-Insulin Degludec (U-100) Vials
- Dipyridamole Injection-Insulin Degludec (U-200) Prefilled Pens
- Dipyridamole Injection-Insulin degludec and liraglutide
- Dipyridamole Injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Dipyridamole Oral, Intravenous
- Insulin aspart, recombinant Subcutaneous-Dipyridamole Tablets
- Insulin aspart, recombinant Subcutaneous-Diquinol
- Insulin aspart, recombinant Subcutaneous-Diroximel Fumarate
- Insulin aspart, recombinant Subcutaneous-Disalcid
- Insulin aspart, recombinant Subcutaneous-Diskets